Quantgene Now Has an At-Home Saliva Test to Help Detect Cancer Risk

Keerthi Vedantam

Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.

Quantgene Now Has an At-Home Saliva Test to Help Detect Cancer Risk

Biotech startup Quantgene released an at-home saliva to test for cancer risk, hoping to compete with other genetics companies as it develops even more precise ways to detect the disease.

The Santa Monica-based company, which aims to extend human life by a decade, released an at-home DNA sequencing test to the public last month to help customers understand hereditary factors that may lead to a cancer diagnosis.


This is one part of Quantgene's four-pronged cancer test, known as Serenity, that uses family history, genetics counselors, a blood test and exome sequencing to scan large chunks of DNA. The company ultimately aims to catch cancer in its first and second stages of development, before it becomes deadly.

"We hope to unlock a new era in medicine in which trained physicians can detect multiple cancers at early stages in the blood with single molecule precision," Quantgene CEO and founder Jo Bhadki said in an announcement.

People can request an at-home saliva test from Quantgene's website and have a genetic counselor interpret its results. According to the company, the cost is less than $1,000 and the test also looks at the risk for other diseases.

The company is also working on a blood test that screens for multiple cancers using a single draw. Quantgene has been working on this early-detection cancer technology for the last five years and is accepting patients via waitlist.

Earlier this week, announced it secured $6 million in funding led by Vikor Scientific, a life science company based out of South Carolina. As part of the investment, Vikor will take a stake in the company and help market Quantgene's services to its database of medical providers, establishing a presence on the East Coast.

The idea for Quantgene began at an U.C. Berkley lab. The company has raised $13 million from two previous rounds of fundraising.

The company aims to establish Los Angeles and South Carolina, where Vikor is headquartered, as "leading centers in genomics-based medical innovation."

Editor's note: This post has been updated to reflect when the saliva-test was released, correct the investment figures in funding rounds and clarify U.C. Berkeley's role in the company's development.

https://twitter.com/KeerthiVedantam
keerthi@dot.la

Subscribe to our newsletter to catch every headline.

Cadence

LA Tech ‘Moves’: Adtech Firm OpenX Lures New SVP, Getlabs and DISQO Tap New VPs

Decerry Donato

Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

LA Tech ‘Moves’: Adtech Firm OpenX Lures New SVP, Getlabs and DISQO Tap New VPs
Photo by James Opas | Modified by Joshua Letona

“Moves,” our roundup of job changes in L.A. tech, is presented by Interchange.LA, dot.LA's recruiting and career platform connecting Southern California's most exciting companies with top tech talent. Create a free Interchange.LA profile here—and if you're looking for ways to supercharge your recruiting efforts, find out more about Interchange.LA's white-glove recruiting service by emailing Sharmineh O’Farrill Lewis (sharmineh@dot.la). Please send job changes and personnel moves to moves@dot.la.

Read moreShow less

This Week in ‘Raises’: Miracle Miles Lands $100M, Fintech Startup Tapcheck Hauls $20M

Decerry Donato

Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.

This Week in ‘Raises’: Miracle Miles Lands $100M, Fintech Startup Tapcheck Hauls $20M
Image by Joshua Letona

In this week’s edition of “Raises”: An L.A.-based footwear company closed $100 million to boost its expansion into the global market, while there were Series A raises for local fintech, biotech and space startups.

Read moreShow less
RELATEDEDITOR'S PICKS
LA TECH JOBS
interchangeLA
Trending